Komori
ASKA Pharmaceutical Holdings (4886) · FactAdvanced

Group Structure Comprising Subsidiaries and Affiliates

First written in FY2022-Q1. 9 of 13 entries say "Restated". Latest entry: FY2026.

13entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q1 – FY2025-H1AdvancedFY2025 – FY20262021: 220212022: 220222023: 320232024: 320242025: 220252026: 12026
Same theme, other companies
Ongoing Expansion of Consolidated Subsidiaries and Equity-Method AffiliatesA theme 35 companies write about · 0 as a headwind · 27 as a tailwind

13 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 35 companies compared. The sentences above are computed from all 35.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「当社グループ(当社および当社の関係会社)は、当社、子会社5社、関連会社6社により構成されており」

    Ha Tay Pharmaceuticalの連結子会社化に加え、FTS Ambrose Holdings, Inc.およびTomodachi I.P. Holdings Inc.等を含むグループ構成を、子会社5社・関連会社6社として記載している。
  2. FY2026-H1AdvancedAnnual report

    「当中間連結会計期間において、株式取得により、FTS Ambrose Holdings, Inc.及びTomodachi I.P. Holdings Inc.の2社を持分法適用関連会社にしております。」

    株式取得により、FTS Ambrose Holdings, Inc.およびTomodachi I.P. Holdings Inc.の2社を持分法適用関連会社としたことで、グループ構成が変化している。
  3. FY2025AdvancedAnnual report

    「当社グループ(当社および当社の関係会社)は、当社、子会社5社、関連会社4社により構成されており」

    従来の子会社3社・関連会社5社から、Ha Tay Pharmaceutical Joint Stock Company等の連結子会社化を経て、子会社5社・関連会社4社の構成となった。
  4. FY2025-H1RestatedAnnual report

    「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the interim consolidated accounting period under review. There were also no changes among the principal affiliated companies.」

    The Company reaffirms that there were no material changes in its business or principal affiliated companies.
  5. FY2024RestatedAnnual report

    「The group, comprising the company and its affiliates, consists of the company, 3 subsidiaries and 5 affiliates. The principal business activities and the role of each company in those businesses are as follows.」

    子会社3社・関連会社5社からなるグループ構成を再掲している。
  6. FY2024-Q3RestatedAnnual report

    「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative third quarter under review. There were also no changes among the principal affiliated companies.」

    The Company reaffirms that there were no material changes in its business or principal affiliated companies.
  7. FY2024-Q2RestatedAnnual report

    「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the second quarter of the current consolidated cumulative period. There were also no changes among the principal affiliated companies.」

    The Company reaffirms that there were no material changes in its business or principal affiliated companies.
  8. FY2024-Q1RestatedAnnual report

    「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative first quarter under review. There were also no changes among the principal affiliated companies.」

    事業内容および主要な関係会社に重要な変更・異動がないことを記載し、グループ構成の継続を再確認している。
  9. FY2023-Q3RestatedAnnual report

    「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative third quarter under review. There were also no changes among the principal affiliated companies.」

    事業内容および主要な関係会社に重要な変更・異動がないことを記載し、グループ構成の継続を再確認している。
  10. FY2022RestatedAnnual report

    「The group, comprising the company and its affiliates, consists of the company, 3 subsidiaries and 5 affiliates. The principal business activities and the role of each company in those businesses are as follows.」

    子会社3社・関連会社5社からなるグループ構成を再掲している。
  11. FY2022-Q3RestatedAnnual report

    「The group, comprising the company and its affiliates, consists of the company, 3 subsidiaries and 5 affiliates. The principal business activities and the role of each company in those businesses are as follows.」

    子会社3社・関連会社5社からなるグループ構成を再掲している。
  12. FY2022-Q2RestatedAnnual report

    「The group, comprising the company and its affiliates, consists of the company, 3 subsidiaries and 5 affiliates. The principal business activities and the role of each company in those businesses are as follows.」

    グループ構成を子会社3社・関連会社5社として再掲している。
  13. FY2022-Q1First statedAnnual report

    「The group, comprising the company and its affiliates, consists of the company, 3 subsidiaries and 5 affiliates. The principal business activities and the role of each company in those businesses are as follows.」

    The group's structure at the time of its establishment is described as comprising 3 subsidiaries and 5 affiliates.
Moved together

"Overseas Business Expansion Focused on Asia" moved the same way as this thread, in the same document, in 3 of its 13 moves.

333222★123456
  1. ★This thread
  2. 1Overseas Business Expansion Focused on Asia3×
  3. 2Continued Investment in R&D and Production Facilities3×
  4. 3Revenue and Profit Growth in the Animal Health Business3×
  5. 4FY2025 Sales and Profitability Targets and the Vision of a Total Healthcare Company2×
  6. 5CO2 Emissions Reduction and Energy-Saving Targets2×
  7. 6Addition of Overseas Business as a Reportable Segment2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
ASKA Pharmaceutical Holdings's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.